Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Mackness

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Biochemical Pharmacology|August 1, 1983
Partial purification and properties of sheep serum "A'-esterasesM I Mackness, C H Walker
Biochemical Pharmacology|April 15, 1981
'A'-esterase activity in the lipoprotein fraction of sheep serumM I Mackness, C H Walker
Journal of Internal Medicine|September 17, 2005
The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitusB Mackness, P McElduff, M I Mackness
Current Opinion in Lipidology|August 17, 2000
How high-density lipoprotein protects against the effects of lipid peroxidationM I Mackness, P N Durrington, B Mackness
Atherosclerosis|June 17, 2000
The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2)S Arrol, M I Mackness, P N Durrington
FEBS Letters|July 29, 1991
Paraoxonase prevents accumulation of lipoperoxides in low-density lipoproteinM I Mackness, S Arrol, P N Durrington
Lancet (London, England)|February 16, 1999
Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidationB Mackness, P N Durrington, M I Mackness
Biochemical and Biophysical Research Communications|June 27, 1998
Lack of protection against oxidative modification of LDL by avian HDLB Mackness, P N Durrington, M I Mackness
Lancet (London, England)|August 18, 2004
Paraoxonase polymorphisms and coronary heart diseaseP N Durrington, B Mackness, M I Mackness
Biochemical Society Transactions|August 1, 1991
Substrate specificity of human serum paraoxonaseM I Mackness, S Arrol, P N Durrington
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|August 1, 1983
Partial purification and properties of sheep serum "A'-esterasesM I Mackness, C H Walker
Biochemical Pharmacology|April 15, 1981
'A'-esterase activity in the lipoprotein fraction of sheep serumM I Mackness, C H Walker
Journal of Internal Medicine|September 17, 2005
The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitusB Mackness, P McElduff, M I Mackness
Current Opinion in Lipidology|August 17, 2000
How high-density lipoprotein protects against the effects of lipid peroxidationM I Mackness, P N Durrington, B Mackness
Atherosclerosis|June 17, 2000
The effects of fatty acids on apolipoprotein B secretion by human hepatoma cells (HEP G2)S Arrol, M I Mackness, P N Durrington
FEBS Letters|July 29, 1991
Paraoxonase prevents accumulation of lipoperoxides in low-density lipoproteinM I Mackness, S Arrol, P N Durrington
Lancet (London, England)|February 16, 1999
Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidationB Mackness, P N Durrington, M I Mackness
Biochemical and Biophysical Research Communications|June 27, 1998
Lack of protection against oxidative modification of LDL by avian HDLB Mackness, P N Durrington, M I Mackness
Lancet (London, England)|August 18, 2004
Paraoxonase polymorphisms and coronary heart diseaseP N Durrington, B Mackness, M I Mackness
Biochemical Society Transactions|August 1, 1991
Substrate specificity of human serum paraoxonaseM I Mackness, S Arrol, P N Durrington
Pageof 10